Answers are grounded in this paper and cite their sources.
Carbapenem resistance and hypervirulence are reported to be converging in Klebsiella pneumoniae, but the reported frequency depends on how a hypervirulent genotype is defined. We analysed the NCBI Pathogen Detection Klebsiella organism group metadata (PDG000000012.2542, downloaded 6 October 2026) and included 131,090 K. pneumoniae genomes with an assembly and AMRFinderPlus output. Carbapenemase genes were assigned to families from pre-specified allele lists. The primary hypervirulence-associated genotype was at least four of the five biomarkers validated against a murine sepsis model (iucA, iroB, peg-344, rmpA, rmpA2); a permissive secondary definition (iucA and/or rmpA/rmpA2) and nine further definitions were analysed in parallel. Proportions are reported with Wilson 95% confidence intervals, and regression models with standard errors clustered on BioProject and on Pathogen Detection single-nucleotide polymorphism (SNP) cluster. A carbapenemase gene was present in 58.80% (95% CI 58.53–59.07) of genomes. Under the primary definition, 5.71% (5.59–5.84) of genomes carried the genotype and 1.03% (0.96–1.10) of carbapenemase-positive genomes were convergent, with no statistically detectable change in the odds per year of collection between 2010 and 2025 (odds ratio 0.99, SNP-cluster-clustered 95% CI 0.93–1.05); in this deposited sample the genotype was twelve times more common in carbapenemase-negative genomes (12.39%, 12.12–12.68). Under the secondary definition the corresponding figures were 24.59% and 28.18% (27.87–28.50), with an 18% rise in the odds per year (1.18, clustered 1.11–1.26), but 54.99% of the genomes it counted carried iucA alone. De-replication to one genome per SNP cluster halved the secondary-definition estimate to 13.70% (13.15–14.26) and left the primary one at 2.31% (2.08–2.57). Convergence estimates for this organism are therefore governed by the definition applied and by clonal redundancy in the archive. These are genotype frequencies in a convenience sample of deposited genomes, not population prevalences, and neither definition demonstrates the hypervirulent phenotype.
No takes yet. Share an insight, caveat, or question.
Alaa Talal Qumsani (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: